These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 30372845)
1. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice. Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845 [TBL] [Abstract][Full Text] [Related]
2. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice. Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998 [TBL] [Abstract][Full Text] [Related]
3. A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor α. Liu Z; Song L; Wang Y; Xu P; Guo X; Yang J; Liu H; Wang Y; Wu C; Zhang T; Yu D; Opoku YK; Khoso MH; Ren G; Li D Int J Pharm; 2018 Aug; 547(1-2):72-82. PubMed ID: 29803792 [TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
5. Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice. Shobeiri SS; Dashti M; Pordel S; Rezaee M; Haghnavaz N; Moghadam M; Ansari B; Sankian M Cytokine; 2023 Dec; 172():156406. PubMed ID: 37879125 [TBL] [Abstract][Full Text] [Related]
6. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related]
7. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840 [TBL] [Abstract][Full Text] [Related]
8. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice. Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541 [TBL] [Abstract][Full Text] [Related]
9. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695 [TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV suppresses the proliferation and inflammatory response of human epidermal keratinocytes and ameliorates imiquimod-induced psoriasis-like skin damage in mice. Liu T; Ai L; Jiang A; Wang Y; Jiang R; Liu L Allergol Immunopathol (Madr); 2024; 52(5):44-50. PubMed ID: 39278850 [TBL] [Abstract][Full Text] [Related]
12. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies. Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659 [TBL] [Abstract][Full Text] [Related]
14. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470 [TBL] [Abstract][Full Text] [Related]
15. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells. Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999 [TBL] [Abstract][Full Text] [Related]
16. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
17. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis. Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833 [TBL] [Abstract][Full Text] [Related]
19. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice. Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383 [TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]